Toxicity of extended adjuvant endocrine with aromatase inhibitors in patients with postmenopausal breast cancer: A Systemtic review and Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toxicity of extended adjuvant endocrine with aromatase inhibitors in patients with postmenopausal breast cancer: A Systemtic review and Meta-analysis

Published:2020-12 Issue: Volume:156 Page:103114
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Zhao Fuxing,Ren Dengfeng,Shen Guoshuang,Ahmad Raees,Dong Li,Du Feng,Zhao Jiuda

Funder

Innovation Team about the Study of Pathogenesis

Anti-tumor Mechanism of Chinese-Tibetan Medicine

Qinghai province Medical Gene Detection Technology Platform

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference63 articles.

1. Prognostic significance of subtype classification for short-and long-term survival in breast Cancer: survival time holds the key;Ambs;PLoS Med.,2010

2. Toxicity of adjuvant endocrine therapy in postmenopausal breast Cancer patients: a systematic review and meta-analysis;Amir;J. Natl. Cancer Inst.,2011

3. Management of cardiovascular disease in women with breast Cancer;Barish;Circulation,2019

4. OPtimal duration of extended adjuvant endocrine therapy for early breast Cancer; results of the IDEAL trial (BOOG 2006-05);Blok;JNCI J. Natl. Cancer Inst.,2018

5. Adjuvant Endocrine Therapy for Women with Hormone Receptor–Positive Breast Cancer;Burstein,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415;Supportive Care in Cancer;2024-07-19

2. Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis;Breast Cancer Research and Treatment;2023-10-03

3. Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer;Breast Cancer Research and Treatment;2023-09-09

4. Extended Adjuvant Endocrine Therapy in Early Breast Cancer Patients—Review and Perspectives;Cancers;2023-08-21

5. In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia;Cancers;2023-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3